Drug Shortage Report for FOLIC ACID INJECTION, USP

Last updated on 2022-01-20 History
Report ID 152914
Drug Identification Number 02139480
Brand name FOLIC ACID INJECTION, USP
Common or Proper name FOLIC ACID INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) FOLIC ACID
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 1
ATC code B03BB
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-14
Actual start date 2022-01-14
Estimated end date 2022-01-20
Actual end date 2022-01-20
Shortage status Resolved
Updated date 2022-01-20
Company comments Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Folic Acid for Injection 5mg/mL Vial 10mL effective today, January 14, 2022 until January 20, 2022.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-01-20 French Compare
v3 2022-01-20 English Compare
v2 2022-01-17 French Compare
v1 2022-01-17 English Compare

Showing 1 to 4 of 4